FDA Adverse Event Malfunction Summary report: N

BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER

MDR report key: 7790468 · Received August 16, 2018

Report

Report Number
1710034-2018-00562
Event Type
Malfunction
Date Received
August 16, 2018
Date of Event
July 31, 2018
Report Date
September 11, 2018
Manufacturer
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Product Code
FOZ
UDI-DI
30382903825333
PMA / PMN Number
K110443
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

DUE TO AN IT ISSUE BEGINNING ON (B)(6) 2018, PREVIOUSLY FILED EMDRS DID NOT CONTAIN REQUIRED FIELDS. THIS SUPPLEMENTAL EMDR IS FILED TO PROVIDE THE FOLLOWING OMITTED FIELDS: EVENT ATTRIBUTED TO: OTHER. DEVICE SINGLE USE?: NO. DEVICE RETURNED TO MANUFACTURE: NO. SAMPLES NOR PHOTOS WERE PROVIDED FOR EVALUATION OF THIS INCIDENT. DHR FOR THIS LOT WAS PREVIOUSLY REVIEWED FOR PR 436937-474549 CR; WHICH DISCLOSED THE FOLLOWING: LOT 8051797; WAS BUILT ON AFA LINE 11 FROM (B)(6) 2018 THRU (B)(6) 2018. ALL REQUIRED CHALLENGES SAMPLES AND TESTING WAS PERFORMED PER SPECIFICATION IN ACCORDANCE WITH THE SETUP AND IN-PROCESS SAMPLING PLANS. IN PROCESS SAMPLING WAS PERFORMED ON VARIOUS STAGES THROUGHOUT THE PROCESS, ALL THE INSPECTIONS PASSED PER SPECIFICATIONS. NO SIGNIFICANT DISCOVERIES WERE FOUND THERE WERE NO REJECT ACTIVITY FINDINGS THROUGHOUT THE BUILD OF THIS LOT THAT WOULD IMPACT UPON THE QUALITY OF THE PRODUCT. SAP (QN) DATABASE REVIEW; WAS CONDUCTED FOR THIS INVESTIGATION WHICH DISCLOSED THAT THERE WERE NO REJECT ACTIVITY FINDINGS RELEVANT TO THE REPORTED DEFECT ASSOCIATED WITH THE LOT NUMBER PROVIDED FOR THIS INCIDENT AS NO QNS WERE INITIATED. ANALYSIS OF PEURA (END USER RISK ANALYSIS) DISCLOSED THAT DUE TO LOW OCCURRENCE AND LIMITED SEVERITY, CURRENT RISK IS ACCEPTABLE. AS UNITS NOR PHOTOS WERE NOT PROVIDED FOR OBSERVATION AND/OR TESTING OF THIS INCIDENT THEREFORE THE ALLEGED DEFECT WAS NOT IDENTIFIED OR CONFIRMED AND A ROOT CAUSE WAS NOT ESTABLISHED. CUSTOMER COMPLAINT TRENDS ARE EVALUATED ON A MONTHLY BASIS. IF THE TREND OF A SPECIFIC TYPE OF COMPLAINT WARRANTS A FORMAL CORRECTIVE ACTION, RESOURCES WILL BE ASSIGNED AT THAT TIME. PRODUCT QUALITY IS EVALUATED DURING THE MANUFACTURING PROCESS WITH PRESCRIBED VARIABLE AND ATTRIBUTES INSPECTIONS. THESE INSPECTIONS ARE PERFORMED BY OPERATORS AND/OR PROCESS CONTROL TECHNICIANS TO ENSURE ANY GROSS PROCESS CHANGES ARE IDENTIFIED. IF DEFECTS ARE OBSERVED, DISPOSITION OF THE PRODUCT, ROOT CAUSE AND CORRECTIVE ACTION ARE APPLIED ACCORDING TO THE QUALITY CONTROL PLAN.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD INSYTE AUTOGUARD BC SHIELDED IV CATHETER HAD A SPLIT CATHETER. NO SERIOUS INJURY OR MEDICAL INTERVENTION WAS REPORTED.

Additional Manufacturer Narrative · 1

DATE OF EVENT: UNKNOWN. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER HAD A SPLIT CATHETER. NO SERIOUS INJURY OR MEDICAL INTERVENTION WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
628903 BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER INTRAVASCULAR CATHETER FOZ BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 8051797 30382903825333

Patients

Seq Age Sex Outcome Treatment
1 Other